FIELD: medicine, cardiology, pharmacy.
SUBSTANCE: invention relates to pharmaceutical composition comprising atenolol as an active component and additives - starch, magnesium basic carbonate, polyvinylpyrrolidone and/or starch glycolate sodium salt, gelatin and stearate; or starch, polyvinylpyrrolidone, stearate, aerosil and microcrystalline cellulose. Composition shows improved physical-mechanical properties.
EFFECT: improved pharmaceutical properties of composition.
14 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING CARDIOSELECTIVE BETA-ADRENOBLOCKER | 2001 |
|
RU2190397C1 |
| ANTIHISTAMINE PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2264814C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
| ANTI-ARRHYTHMIC, ANTI-ANGINAL PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2212236C1 |
| PHARMACEUTICAL ANTIULCEROUS COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2179022C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-DIARRHEA EFFECT | 2004 |
|
RU2276979C2 |
| SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
| SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2222333C1 |
| ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
